Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Olmos, Dr.
Hospital 12 de Octubre
Study Chair - Elena Castro, Dra.
Hospital 12 de Octubre
Principal Investigator - Maria Ruiz Vico, Dra.
Hospital 12 de Octubre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Català D'Oncologia (ico)
Badalona, Barcelona, Spain
Recruiting - Consorcio Corporación Sanitaria Parc Taulí
Sabadell, Barcelona, Spain
Recruiting - Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Recruiting - Hospital Universitario de Jerez de la Frontera
Cadiz, Cádiz, Spain
Recruiting - Hospital Universitario Cruces
Barakaldo, Vizcaya, Spain
Recruiting - Hospital Clínico Y Provincial de Barcelona
Barcelona, Spain
Recruiting - Hospital Universitario del Mar.
Barcelona, Spain
Recruiting - Hospital 12 de Octubre
Madrid, Spain
Recruiting - Hospital Clínico San Carlos
Madrid, Spain
Recruiting - Hospital Universitario la Paz
Madrid, Spain
Recruiting - Hospital Universitario Virgen de la Victoria
Málaga, Spain
Recruiting - Hospital Universitario Miguel Servet
Zaragoza, Spain
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2024
- Primary completion
- 31 Jan 2026
- Completion
- 31 Oct 2027
- Last update posted
- 2 Dec 2024
- Registered enrollment
- 78
- Registry id
- NCT06582628
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.